BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 34203690)

  • 21. BET bromodomain proteins are required for glioblastoma cell proliferation.
    Pastori C; Daniel M; Penas C; Volmar CH; Johnstone AL; Brothers SP; Graham RM; Allen B; Sarkaria JN; Komotar RJ; Wahlestedt C; Ayad NG
    Epigenetics; 2014 Apr; 9(4):611-20. PubMed ID: 24496381
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Structure-Based Discovery and Optimization of Benzo[ d]isoxazole Derivatives as Potent and Selective BET Inhibitors for Potential Treatment of Castration-Resistant Prostate Cancer (CRPC).
    Zhang M; Zhang Y; Song M; Xue X; Wang J; Wang C; Zhang C; Li C; Xiang Q; Zou L; Wu X; Wu C; Dong B; Xue W; Zhou Y; Chen H; Wu D; Ding K; Xu Y
    J Med Chem; 2018 Apr; 61(7):3037-3058. PubMed ID: 29566488
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bioactivation of glafenine by human liver microsomes and peroxidases: identification of electrophilic iminoquinone species and GSH conjugates.
    Wen B; Moore DJ
    Drug Metab Dispos; 2011 Sep; 39(9):1511-21. PubMed ID: 21628497
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bromodomain and Extra-terminal (BET) Protein Inhibitors Suppress Chondrocyte Differentiation and Restrain Bone Growth.
    Niu N; Shao R; Yan G; Zou W
    J Biol Chem; 2016 Dec; 291(52):26647-26657. PubMed ID: 27821592
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Phase I Metabolism of Pterostilbene, a Dietary Resveratrol Derivative: Metabolite Identification, Species Differences, Isozyme Contribution, and Further Bioactivation.
    Li Y; Sun C; Zhang Y; Chen X; Huang H; Han L; Xing H; Zhao D; Chen X; Zhang Y
    J Agric Food Chem; 2023 Jan; 71(1):331-346. PubMed ID: 36538288
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Formation and reactivity of alternative quinone methides from butylated hydroxytoluene: possible explanation for species-specific pneumotoxicity.
    Bolton JL; Sevestre H; Ibe BO; Thompson JA
    Chem Res Toxicol; 1990; 3(1):65-70. PubMed ID: 2131827
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Bromodomain and Extra-Terminal Domain (BET) Family: Functional Anatomy of BET Paralogous Proteins.
    Taniguchi Y
    Int J Mol Sci; 2016 Nov; 17(11):. PubMed ID: 27827996
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Discovery, Design, and Optimization of Isoxazole Azepine BET Inhibitors.
    Gehling VS; Hewitt MC; Vaswani RG; Leblanc Y; Côté A; Nasveschuk CG; Taylor AM; Harmange JC; Audia JE; Pardo E; Joshi S; Sandy P; Mertz JA; Sims RJ; Bergeron L; Bryant BM; Bellon S; Poy F; Jayaram H; Sankaranarayanan R; Yellapantula S; Bangalore Srinivasamurthy N; Birudukota S; Albrecht BK
    ACS Med Chem Lett; 2013 Sep; 4(9):835-40. PubMed ID: 24900758
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Elucidation of a novel bioactivation pathway of a 3,4-unsubstituted isoxazole in human liver microsomes: formation of a glutathione adduct of a cyanoacrolein derivative after isoxazole ring opening.
    Yu J; Folmer JJ; Hoesch V; Doherty J; Campbell JB; Burdette D
    Drug Metab Dispos; 2011 Feb; 39(2):302-11. PubMed ID: 21045198
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lung toxicity and tumor promotion by hydroxylated derivatives of 2,6-di-tert-butyl-4-methylphenol (BHT) and 2-tert-butyl-4-methyl-6-iso-propylphenol: correlation with quinone methide reactivity.
    Kupfer R; Dwyer-Nield LD; Malkinson AM; Thompson JA
    Chem Res Toxicol; 2002 Aug; 15(8):1106-12. PubMed ID: 12184795
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Reactivity
    Ali K; Mishra P; Kumar A; Reddy DN; Chowdhury S; Panda G
    Chem Commun (Camb); 2022 May; 58(42):6160-6175. PubMed ID: 35522910
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bioactivation of isothiazoles: minimizing the risk of potential toxicity in drug discovery.
    Teffera Y; Choquette D; Liu J; Colletti AE; Hollis LS; Lin MH; Zhao Z
    Chem Res Toxicol; 2010 Nov; 23(11):1743-52. PubMed ID: 20825217
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification of a novel series of BET family bromodomain inhibitors: binding mode and profile of I-BET151 (GSK1210151A).
    Seal J; Lamotte Y; Donche F; Bouillot A; Mirguet O; Gellibert F; Nicodeme E; Krysa G; Kirilovsky J; Beinke S; McCleary S; Rioja I; Bamborough P; Chung CW; Gordon L; Lewis T; Walker AL; Cutler L; Lugo D; Wilson DM; Witherington J; Lee K; Prinjha RK
    Bioorg Med Chem Lett; 2012 Apr; 22(8):2968-72. PubMed ID: 22437115
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Discovery of Benzo[
    Jiang F; Hu Q; Zhang Z; Li H; Li H; Zhang D; Li H; Ma Y; Xu J; Chen H; Cui Y; Zhi Y; Zhang Y; Xu J; Zhu J; Lu T; Chen Y
    J Med Chem; 2019 Dec; 62(24):11080-11107. PubMed ID: 31789032
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The BET bromodomain inhibitor i-BET151 impairs ovarian cancer metastasis and improves antitumor immunity.
    Liu A; Fan D; Wang Y
    Cell Tissue Res; 2018 Dec; 374(3):577-585. PubMed ID: 30182276
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The suppression of bromodomain and extra-terminal domain inhibits vascular inflammation by blocking NF-κB and MAPK activation.
    Huang M; Zeng S; Zou Y; Shi M; Qiu Q; Xiao Y; Chen G; Yang X; Liang L; Xu H
    Br J Pharmacol; 2017 Jan; 174(1):101-115. PubMed ID: 27774624
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bioactivation of phencyclidine in rat and human liver microsomes and recombinant P450 2B enzymes: evidence for the formation of a novel quinone methide intermediate.
    Driscoll JP; Kornecki K; Wolkowski JP; Chupak L; Kalgutkar AS; O'Donnell JP
    Chem Res Toxicol; 2007 Oct; 20(10):1488-97. PubMed ID: 17892269
    [TBL] [Abstract][Full Text] [Related]  

  • 38. BET bromodomain inhibitors: fragment-based in silico design using multi-target QSAR models.
    Speck-Planche A; Scotti MT
    Mol Divers; 2019 Aug; 23(3):555-572. PubMed ID: 30421269
    [TBL] [Abstract][Full Text] [Related]  

  • 39. XenoNet: Inference and Likelihood of Intermediate Metabolite Formation.
    Flynn NR; Dang NL; Ward MD; Swamidass SJ
    J Chem Inf Model; 2020 Jul; 60(7):3431-3449. PubMed ID: 32525671
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Structure-guided discovery of a novel, potent, and orally bioavailable 3,5-dimethylisoxazole aryl-benzimidazole BET bromodomain inhibitor.
    Sperandio D; Aktoudianakis V; Babaoglu K; Chen X; Elbel K; Chin G; Corkey B; Du J; Jiang B; Kobayashi T; Mackman R; Martinez R; Yang H; Zablocki J; Kusam S; Jordan K; Webb H; Bates JG; Lad L; Mish M; Niedziela-Majka A; Metobo S; Sapre A; Hung M; Jin D; Fung W; Kan E; Eisenberg G; Larson N; Newby ZER; Lansdon E; Tay C; Neve RM; Shevick SL; Breckenridge DG
    Bioorg Med Chem; 2019 Feb; 27(3):457-469. PubMed ID: 30606676
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.